24685637|t|Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
24685637|a|Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are present during the disease course of nearly all AD patients and consist of psychosis, agitation/aggression, and depression, among others. Given their detrimental consequences regarding life expectancy, cognition, and socio-economic costs, it is essential to elucidate their neurochemical etiology to facilitate the development of novel and effective pharmacotherapeutics. This study attempted to identify brain region-specific monoaminergic correlates of NPS by measuring the levels of eight monoamines and metabolites in nine relevant postmortem brain regions of 40 behaviorally characterized AD patients, i.e., dopamine (DA), serotonin (5-HT), (nor)epinephrine and their respective metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid, 5-hydroxy-3-indoleacetic acid (5-HIAA), and 3-methoxy-4-hydroxyphenylglycol (MHPG), using RP-HPLC-ECD. Likewise, Mini-Mental State Examination (MMSE) score correlates of monoaminergic neurotransmitter alterations were calculated. As a result, MMSE scores, used as a measure of dementia severity, correlated positively with hippocampal 5-HIAA levels as well as with 5-HT levels of the superior temporal gyrus and cerebellar cortex. Furthermore, hippocampal 5-HIAA levels inversely correlated with agitation scores, whereas thalamic MHPG levels comparably did with the presence of hallucinations. Finally, in the cerebellar cortex, DOPAC/DA ratios, indicative of DA turnover, correlated with physically agitated behavior while MHPG levels correlated with affective disturbances. These findings support the assumption that specific NPS features in AD might be (in)directly related to brain region-specific monoaminergic neurotransmitter alterations. Additionally, the effect of AD pathology on neurochemical alterations in the cerebellum requires further examination due to its important but underestimated role in the neurochemical pathophysiology of NPS in AD. 
24685637	50	75	neuropsychiatric symptoms	Disease	MESH:D001523
24685637	79	98	Alzheimer's disease	Disease	MESH:D000544
24685637	100	125	Neuropsychiatric symptoms	Disease	MESH:D001523
24685637	127	130	NPS	Disease	MESH:D001523
24685637	135	154	Alzheimer's disease	Disease	MESH:D000544
24685637	156	158	AD	Disease	MESH:D000544
24685637	212	214	AD	Disease	MESH:D000544
24685637	215	223	patients	Species	9606
24685637	239	248	psychosis	Disease	MESH:D011618
24685637	250	259	agitation	Disease	MESH:D011595
24685637	260	270	aggression	Disease	MESH:D010554
24685637	276	286	depression	Disease	MESH:D003866
24685637	619	622	NPS	Disease	MESH:D001523
24685637	656	666	monoamines	Chemical	-
24685637	758	760	AD	Disease	MESH:D000544
24685637	761	769	patients	Species	9606
24685637	777	785	dopamine	Chemical	MESH:D004298
24685637	787	789	DA	Chemical	MESH:D004298
24685637	792	801	serotonin	Chemical	MESH:D012701
24685637	803	807	5-HT	Chemical	MESH:D012701
24685637	815	826	epinephrine	Chemical	MESH:D004837
24685637	860	890	3,4-dihydroxyphenylacetic acid	Chemical	MESH:D015102
24685637	892	897	DOPAC	Chemical	MESH:D015102
24685637	903	920	homovanillic acid	Chemical	MESH:D006719
24685637	922	951	5-hydroxy-3-indoleacetic acid	Chemical	MESH:D006897
24685637	953	959	5-HIAA	Chemical	MESH:D006897
24685637	966	997	3-methoxy-4-hydroxyphenylglycol	Chemical	MESH:D008734
24685637	999	1003	MHPG	Chemical	MESH:D008734
24685637	1092	1122	monoaminergic neurotransmitter	Chemical	-
24685637	1199	1207	dementia	Disease	MESH:D003704
24685637	1257	1263	5-HIAA	Chemical	MESH:D006897
24685637	1287	1291	5-HT	Chemical	MESH:D012701
24685637	1378	1384	5-HIAA	Chemical	MESH:D006897
24685637	1418	1427	agitation	Disease	MESH:D011595
24685637	1453	1457	MHPG	Chemical	MESH:D008734
24685637	1501	1515	hallucinations	Disease	MESH:D006212
24685637	1552	1557	DOPAC	Chemical	MESH:D015102
24685637	1558	1560	DA	Chemical	MESH:D004298
24685637	1583	1585	DA	Chemical	MESH:D004298
24685637	1647	1651	MHPG	Chemical	MESH:D008734
24685637	1675	1697	affective disturbances	Disease	MESH:D019964
24685637	1751	1754	NPS	Disease	MESH:D001523
24685637	1767	1769	AD	Disease	MESH:D000544
24685637	1825	1855	monoaminergic neurotransmitter	Chemical	-
24685637	1897	1899	AD	Disease	MESH:D000544
24685637	2071	2074	NPS	Disease	MESH:D001523
24685637	2078	2080	AD	Disease	MESH:D000544
24685637	Negative_Correlation	MESH:D006897	MESH:D011595
24685637	Association	MESH:D012701	MESH:D000544
24685637	Association	MESH:D004298	MESH:D000544
24685637	Association	MESH:D008734	MESH:D006212
24685637	Association	MESH:D008734	MESH:D019964
24685637	Association	MESH:D006897	MESH:D003704
24685637	Association	MESH:D008734	MESH:D000544

